These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 618708)

  • 21. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios.
    Ho Ngoc-Ta Trung A; Sirois G
    Pharm Acta Helv; 1987; 62(2):61-4. PubMed ID: 3575343
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood collection techniques, heparin and quinidine protein binding.
    Kessler KM; Leech RC; Spann JF
    Clin Pharmacol Ther; 1979 Feb; 25(2):204-10. PubMed ID: 759074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
    Fremstad D; Jacobsen S; Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):161-76. PubMed ID: 579055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dry polyacrylamide batch method for studying drug protein binding.
    Julkunen RJ; Himberg JJ
    Arzneimittelforschung; 1976 Apr; 26(4):560-3. PubMed ID: 989013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma drug binding: implications for anesthesiologists.
    Wood M
    Anesth Analg; 1986 Jul; 65(7):786-804. PubMed ID: 3087239
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of high (3S)-3-hydroxyquinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.
    Drayer DE; Hughes M; Lorenzo B; Reidenberg MM
    Clin Pharmacol Ther; 1980 Jan; 27(1):72-5. PubMed ID: 7351119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic and clinical implications of quinidine protein binding.
    Woo E; Greenblatt DJ
    J Pharm Sci; 1979 Apr; 68(4):466-70. PubMed ID: 438971
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of quinidine in dogs with congestive cardiac failure.
    Jellett LB; Lloyd BL; Taylor RR; Ilett KF
    Pharmacol Res Commun; 1977 May; 9(5):455-63. PubMed ID: 882589
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma.
    Pike E; Skuterud B; Kierulf P; Fremstad D; Abdel Sayed SM; Lunde PK
    Clin Pharmacokinet; 1981; 6(5):367-74. PubMed ID: 7333058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pH on free quinidine.
    Chen BH; Taylor EH; Ackerman BH; Olsen K; Pappas AA
    Drug Intell Clin Pharm; 1988 Oct; 22(10):826. PubMed ID: 3229354
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function.
    Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM
    Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive binding of the bioflavonoid quercetin to human plasma proteins.
    Boulton DW; Walle UK; Walle T
    J Pharm Pharmacol; 1998 Feb; 50(2):243-9. PubMed ID: 9530994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of quinidine in human blood.
    Hughes IE; Ilett KF; Jellett LB
    Br J Clin Pharmacol; 1975 Dec; 2(6):521-5. PubMed ID: 1234016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal quinidine binding in survivors of prehospital cardiac arrest.
    Kessler KM; Lisker B; Conde C; Silver J; Ho-Tung P; Hamburg C; Myerburg RJ
    Am Heart J; 1984 Apr; 107(4):665-9. PubMed ID: 6702560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.